Ten years ago, people with cystic fibrosis (CF) celebrated when the FDA approved ivacaftor, the first drug designed to target the defective protein that causes the disease. CF is an inherited disorder that inflicts severe damage to the lungs, digestive system and other organs in the body. Since then, several additional drugs that use a similar mechanism have been approved by the FDA for CF.
The Colorado Sun
March 28, 2024
Researchers at National Jewish Health conducted some of the earliest studies on using anti-IgE drugs to prevent severe allergic reactions to food
Reuters
March 05, 2024
The study was conducted at the CCTSI's Clinical Translational Research Center.
Health Affairs
February 29, 2024
CCTSI's pilot awardee's project helps launch Denver program that links care, services and housing.
The Conversation
February 21, 2024
The Conversation US asked Dr. Jacob Pellinen, a neurologist specializing in epilepsy, to walk us through how to recognize a seizure in a bystander or loved one and what to do in those crucial moments after a seizure begins. Research is supported by the Colorado Clinical and Translational Sciences Institute.
Wendy Meyer
